Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Natera, Inc. Director's Dealing 2018

Oct 17, 2018

30253_dirs_2018-10-17_6fb97807-5cc2-49c6-94d5-a239a76e0402.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Natera, Inc. (NTRA)
CIK: 0001604821
Period of Report: 2018-10-15

Reporting Person: Sheena Jonathan (Director, Chief Technology Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2018-10-15 Common Stock M 25491 $1.141 Acquired 372583 Direct
2018-10-15 Common Stock M 8233 $2.6569 Acquired 380816 Direct
2018-10-15 Common Stock S 33724 $20.2666 Disposed 347092 Direct
2018-10-15 Common Stock S 50672 $20.2882 Disposed 296420 Direct
2018-10-16 Common Stock M 16276 $1.141 Acquired 312696 Direct
2018-10-16 Common Stock S 7100 $20.6233 Disposed 305596 Direct
2018-10-16 Common Stock S 9176 $21.2194 Disposed 296420 Direct
2018-10-16 Common Stocj S 11791 $20.5347 Disposed 284629 Direct
2018-10-16 Common Stock S 54204 $21.2015 Disposed 230425 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2018-10-15 Stock Option (right to buy) $1.141 M 25491 Disposed 2022-09-19 Common Stock (25491) Direct
2018-10-15 Stock Option (right to buy) $2.6569 M 8233 Disposed 2024-02-25 Common Stock (8233) Direct
2018-10-16 Stock Option (right to buy) $1.141 M 16276 Disposed 2022-09-19 Common Stock (16276) Direct

Footnotes

F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 14, 2018.

F2: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.92 to $20.64 per share, inclusive. The holder undertakesto provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.91 to $20.64 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F4: The option shares vest fully and became exercisable on July 8, 2015.

F5: The option shares vest fully and became exercisable on February 25, 2014.

F6: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.07 to $21.06 per share, inclusive. The holder undertakesto provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F7: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.07 to $21.36 per share, inclusive. The holder undertakesto provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F8: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.00 to $20.99 per share, inclusive. The holder undertakesto provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F9: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.00 to $21.41 per share, inclusive. The holder undertakesto provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F10: The Form 4 filed on November 25, 2016 ("Prior Filing") reflects an exercise of a stock option for 25,895 shares. The Prior Filing inadvertently included the exercise of 2,413 shares from a separate option granted to the Reporting Person on the same date understating the total amount beneficially owned following the reported transaction by 2,413 shares. The aggregate number of shares exercised on November 22, 2016 is correct as shown in Column 5. Prior to the transactions reported on this Form 4 the Reporting Person had a total of 41,767 shares remaining to exercise under the stock option.